BOSTON, September 23, 2025--(BUSINESS WIRE)--Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, today announced the addition of a tissue-informed ...
Foundation Medicine’s flagship cancer diagnostic is designed to detect substitutions and alterations in more than 300 genes—and the company seemingly won’t rest until the test has been cleared for use ...
The pharmaceutical giant Roche plans to spend $1 billion to acquire majority control of Foundation Medicine, a five-year old company that developed an innovative DNA test to match patients to specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results